Cargando…
Cardiotoxicity of anthracycline-free targeted oncological therapies in HER2-positive breast cancer
Anthracycline drugs are considered to be pivotal drugs in numerous chemotherapy regimens for breast cancer. However, the cardiotoxicity associated with the treatment is an important issue to be addressed. With the emergence of increasingly diverse antitumor drugs, anthracycline-free therapies are ab...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
D.A. Spandidos
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7751370/ https://www.ncbi.nlm.nih.gov/pubmed/33376533 http://dx.doi.org/10.3892/ol.2020.12361 |